MRD / Regn No. : 20260000703 Date : 23/07/2026
Patient Name : Rajiv Kyal Age & Gender : 54 Yrs. / Male
Contact No. : 9434009093 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Subjective : DM FOR 20 YEARS,HTN,SOMNOLENCE
Objective : NONE
Analysis : A2AG1 DKD,TYPE 2 DM,OBSTRUCTIVE SLEEP APNEA
Plan : ADD TIRZEPATIDE SGLT2I,CONTINUE ARB STATIN,SEE ME IN 1 MONTH,STOP SMOKING  
Salient Investigations : ESR: 5 mm/hour | HEMOGLOBIN: 14.8 g/dL | MCH: 29 pg | MCHC: 33 gm % | MCV: 88 fl | PCV: 45 % | PLATELETS: 321 thou cells/ ul | RBC COUNT: 5.14 million/ul | TOTAL COUNT WBC: 12.27 Cells/cmm | FASTING PLASMA GLUCOSE (FPG): 134 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 8.6 % | POST PRANDIAL GLUCOSE (2HPP): 212 mg/dL | UREA: 21 mg/dL | CREATININE: 0.89 mg/dL | URIC ACID: 7.3 | HDL HIGH DENSITY LIPOPROTEIN: 39 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 63 mg/dL | TGL TRIGLYCERIDE: 136 mg/dL | TOTAL CHO/HDL RATIO: 3.1 | TOTAL CHOLESTEROL: 120 mg/dl | A\G RATIO: 1.47 g/dl | ALBUMIN (SERUM): 4.35 g/dL | ALKALINE PHOSPHOTASE: 73 IU/L | DIRECT BILIRUBIN: 0.24 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 34 U/L | GLOBULIN: 2.96 g/dl | INDIRECT BILIRUBIN: 0.35 | SGOT (AST): 28 U/L | SGPT (ALT): 40 IU/L | TOTAL BILIRUBIN: 0.59 mg/dL | TOTAL PROTEIN: 7.31 g/dl | VITAMIN D (25 OH): 44.5 ng/mL | VITAMIN B12: 1545 pg/mL | PHOSPHORUS: 4.2 mg/dl | CALCIUM: 9.9 mg/DL | TSH : 1.700 mIU/L | PROSTATE SPECIFIC ANTIGEN (PSA): 4.290 ng/mL | VLDL: 27 mg/dl | BICARBONATE: 26 meq/L | CHLORIDE: 102 meq/L | POTASSIUM: 5.0 meQ/L | SODIUM: 140 meq/L | FREE T4 : 1.20 ng/dL | NT PROBNP : 104 pg/mL | HIGH SENSITIVE C REACTIVE PROTEIN: 0.26 mg/L | CUP DISC RATIO L: 0.52 | CUP DISK RATIO R: 0.49 | ABI LEFT: 1.03 | ABI RIGHT: 1.03 | EGFR EGLOMERULAR FILTRATION RATE: 94.84 mL/min/1.73m2 | FIB4: 0.75 | EGFR EGLOMERULAR FILTRATION RATE: 94.84 mL/min/1.73m2 | FIB4: 0.75 | EGFR EGLOMERULAR FILTRATION RATE: 94.84 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 94.84 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 94.84 mL/min/1.73m2 | FIB4: 0.75 | FIB4: 0.75 | APNEA HYPOPNEA INDEX: 45.4 | RESPIRATORY DISTRESS INDEX: 49.1 / hour
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION TIRZEPATIDE 2.5 MG
MOUNJARO
Medicine For DIABETES OBESITY 		SQ ONCE A WEEK AS DIRECTED
 TILL NEXT VISIT
MAY CAUSE NAUSEA AND VISUAL DISTURBANCES
2 ROSUVASTATIN 10 MG
CRESTOR 10 MG 		0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY
3 TELMISARTAN 40 MG
ERITEL 40 MG 		0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE HIGH POTASSIUM
4 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 22/Aug/2026
Tests Suggested For Next Visit : FBS 2HPPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: